Status:
RECRUITING
Circulating Tumour Cells Characterization in Breast Cancer Patients
Lead Sponsor:
Istituti Clinici Scientifici Maugeri SpA
Collaborating Sponsors:
Carlo Morasso
Conditions:
Breast Cancer
Eligibility:
FEMALE
18-90 years
Brief Summary
In the current scenario, a reliable liquid biopsy method for predicting outcomes in solid tumors, especially among breast cancer patients, is lacking. Circulating Tumor Cells (CTCs) serve as crucial i...
Detailed Description
This is an experimental, prospective and monocentric study. This study involves consecutive patients with diagnosis of breast cancer (BC), including early breast cancer and metastatic breast cancer pa...
Eligibility Criteria
Inclusion
- female patients with diagnosis of metastatic breast cancer, confirmed by clinical practice staging exams.
- female patients with biopsy-confirmed diagnosis of early-breast cancer candidate for primary surgery after multidisciplinary evaluation.
- patients not affected by any neoplastic disease.
Exclusion
- Diagnosis of any neoplastic disease
Key Trial Info
Start Date :
December 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06048835
Start Date
December 1 2022
End Date
December 31 2025
Last Update
November 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Istituti Clinici Scientifici Maugeri SpA
Pavia, Lombardy, Italy, 27100